What is the Market Size of Biotechnology | Insights, Trends & Growth Analysis 2026

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA10713

Publication Date: Nov 2025

What is the size of Biotechnology Market?

According to 6Wresearch internal database and industry insights, the Global Biotechnology Market was valued at USD 1050 Billion in 2025 and is expected to reach USD 1840 Billion by 2032, growing at a compound annual growth rate of 12.02% during the forecast period (2026-2032).

The main drivers of this growth are the increasing demand for precision therapeutics, rising incidence of chronic and genetic disorders, and rapid advances in gene editing and synthetic biology technologies.

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Global Biotechnology Market.

View Main Report Schedule Analyst Call

Growth Factors for Biotechnology Industry

Escalating investments in R&D enable development of novel biologics and gene therapies.
Rising adoption of personalised medicine supports tailored treatment solutions and broadens application scope.
Growing demand for sustainable bio-based products in agriculture and industry diversifies biotechnology usage.
Integration of artificial intelligence and data analytics enhances drug discovery and shortens time-to‐market.
Favourable regulatory frameworks and expanded reimbursement policies improve commercial viability of biotech solutions.

Biotechnology Market Trends

The Biotechnology Market trends reveal accelerated development of cell and gene therapies alongside automated biomanufacturing platforms driving operational efficiency and cost-reduction. Companies are increasingly collaborating via licensing and partnership models to access novel modalities and expand therapeutic pipelines. Moreover, demand for bioinformatics, multi-omics analytics and AI-driven drug-discovery platforms is intensifying, reshaping the competitive landscape across life science ecosystems.

Emerging Developments in the Biotechnology Market

The Biotechnology Market developments include emergence of next-generation bioprocessing technologies such as continuous manufacturing and modular facilities enabling scalable output. Firms are advancing synthetic biology to produce novel biomaterials, bioplastics and alternative proteins beyond healthcare. Additionally, strategic regional expansion and localisation of supply chains are gaining traction as firms seek cost-efficiencies and access to new markets.